As of May 31, 2025, Echo Therapeutics Inc (ECTE) reports a Current Ratio of 0.09.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Echo Therapeutics Inc's Current Ratio
Over recent years, Echo Therapeutics Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2015-12-31 | 0.09 |
| 2014-12-31 | 0.59 |
| 2013-12-31 | 2.57 |
| 2012-12-31 | 0.54 |
| 2011-12-31 | 3.84 |
This slight downward trend highlights how Echo Therapeutics Inc manages its short-term assets and liabilities over time.
Comparing Echo Therapeutics Inc's Current Ratio to Peers
To better understand Echo Therapeutics Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Echo Therapeutics Inc (ECTE) | 0.09 |
| Photoelectron Corp (PECN) | 6.85 |
| Cell Tech International Inc (EFLI) | 4.97 |
| Speedus Corp (SPDE) | 3.58 |
| Presbia PLC (LENSF) | 2.88 |
| REMSleep Holdings Inc (RMSL) | 1.96 |
Compared to its competitors, Echo Therapeutics Inc's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.